Arcensus
Pre-clinicalArcensus is dedicated to empowering physicians with Whole Genome Sequencing (WGS) insights, pioneering the adoption of WGS as the standard in genetic testing.
Founded
2018
Focus
Diagnostics
About
Arcensus is dedicated to empowering physicians with Whole Genome Sequencing (WGS) insights, pioneering the adoption of WGS as the standard in genetic testing.
Funding History
3Total raised: $42.5M
Series A$30MHeal CapitalJan 15, 2022
Seed$4.5MUndisclosedNov 15, 2020
Seed$8MAtlantic LabsApr 15, 2020
Company Info
TypePrivate
Founded2018
LocationRostock, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile